Repositorio Institucional
Repositorio Institucional
CONICET Digital
  • Inicio
  • EXPLORAR
    • AUTORES
    • DISCIPLINAS
    • COMUNIDADES
  • Estadísticas
  • Novedades
    • Noticias
    • Boletines
  • Ayuda
    • General
    • Datos de investigación
  • Acerca de
    • CONICET Digital
    • Equipo
    • Red Federal
  • Contacto
JavaScript is disabled for your browser. Some features of this site may not work without it.
  • INFORMACIÓN GENERAL
  • RESUMEN
  • ESTADISTICAS
 
Evento

Antitumor activity of Pleurotus ostreatus I-Fraction in a Triple-Negative Breast Cancer murine model

Ferronato, María JuliaIcon ; Alonso, Exequiel GonzaloIcon ; Ibarra, AgustinaIcon ; Clemente, ValentinaIcon ; Cuestas Juan Manuel; Postemsky, Pablo DanielIcon ; Lopez, Olivia ValeriaIcon ; Boldrini, Diego EmmanuelIcon ; Fermento, María EugeniaIcon ; Colo, Georgina PamelaIcon ; Curino, Alejandro CarlosIcon ; Facchinetti, Maria MartaIcon ; Alonso, Eliana NoeliaIcon
Tipo del evento: Congreso
Nombre del evento: LVI Reunión Anual de la Asociación Argentina de Farmacología Experimental
Fecha del evento: 23/10/2024
Institución Organizadora: Asociación Argentina de Farmacología Experimental;
Título del Libro: LVI Reunión Anual De La Asociación Argentina De Farmacología Experimental
Editorial: Asociación Argentina de Farmacología Experimental
Idioma: Inglés
Clasificación temática:
Bioquímica y Biología Molecular

Resumen

Pleurotus ostreatus is an edible mushroom recognized by the Argentine FoodCode. The antitumor activity of its polysaccharides, free or bound to proteins, hasbeen demonstrated in different types of cancer. However, its potential in TripleNegative Breast Cancer (TNBC) is unknown yet. In this context, we have shownthat I-Fraction: a polysaccharide-enriched extract obtained from P. ostreatusexerts antitumor activity on 4T1 and MDA-MB-231 TNBC cell lines in cultive.Therefore, the objectives of this work are to determine the antitumor activity invivo of I-Fraction in TNBC and to deepen its physical-chemical characterization.To this end, we employed a 4T1 syngeneic murine model in which BALB/c micebearing TNBC tumors were treated with I-Fraction extract (25 mg/kg or 50 mg/kg)or vehicle (PBS 1x), 5 times a week for 3 weeks (total doses = 15; subcutaneouslyin the periphery of the tumor). We found that treatment with 50 mg/kg of I-Fractionretarded tumor growth in vivo. From the eleventh dose, I-Fraction-treated micehad significantly smaller tumors than vehicle-treated mice (p < 0.05). In additionto this, the ex vivo tumor volume and weight developed under treatment with 50mg/kg of I-Fraction were significantly lower compared to vehicle treatment (p <0.01). Furthermore, we found a lower number of lung metastases per animal in50 mg/kg I-Fraction-treated mice than in the vehicle-treated mice (p = 0.001).Also, the treatment with I-Fraction did not affect the weight of the mice or theirinternal organs, nor did it alter hematological and biochemical parameters. Onthe other hand, by thermogravimetric analysis, we determined that I-Fractioncontains a moisture of 6.6%, a residue of 12.8% at 700 ºC and a degradationstart temperature of 139.3 ºC. Furthermore, differential scanning calorimetrythermograms showed an exothermic event at 280.7 ºC (∆H=225.6 J/g). Inconclusion, these results demonstrate the antitumor activity in vivo of P. ostreatusI-Fraction in TNBC.
Palabras clave: Pleurotus , Polisacáridos , I Fraction , ex vivo tumor
Ver el registro completo
 
Archivos asociados
Thumbnail
 
Tamaño: 627.4Kb
Formato: PDF
.
Descargar
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/258701
URL: https://aafeargentina.org/congresos-aafe/
Colecciones
Eventos(CERZOS)
Eventos de CENTRO REC.NAT.RENOVABLES DE ZONA SEMIARIDA(I)
Citación
Antitumor activity of Pleurotus ostreatus I-Fraction in a Triple-Negative Breast Cancer murine model; LVI Reunión Anual de la Asociación Argentina de Farmacología Experimental; Bahía Blanca; Argentina; 2024; 34-34
Compartir

Enviar por e-mail
Separar cada destinatario (hasta 5) con punto y coma.
  • Facebook
  • X Conicet Digital
  • Instagram
  • YouTube
  • Sound Cloud
  • LinkedIn

Los contenidos del CONICET están licenciados bajo Creative Commons Reconocimiento 2.5 Argentina License

https://www.conicet.gov.ar/ - CONICET

Inicio

Explorar

  • Autores
  • Disciplinas
  • Comunidades

Estadísticas

Novedades

  • Noticias
  • Boletines

Ayuda

Acerca de

  • CONICET Digital
  • Equipo
  • Red Federal

Contacto

Godoy Cruz 2290 (C1425FQB) CABA – República Argentina – Tel: +5411 4899-5400 repositorio@conicet.gov.ar
TÉRMINOS Y CONDICIONES